Fibromyalgia patients have an imbalance in the number of unfriendly bacteria that reside in their gut
A higher dose of Wegovy (7.2 mg) was approved by the MHRA in January 2026 following the STEP UP trial, which showed: 2 Wegovy 7.2 mg: 20.7% average weight loss Wegovy 2.4 mg: 17.5% average weight loss 50.9% of those on 7.2 mg lost at least 20% of body weight The 7.2 mg dose is not a starting dose
CAT mRNA levels were significantly higher in SHR aged 2, 4, 6 and 12 weeks
Dibutyryl-cGMP, a synthetic cGMP derivative, reduces ionomycin-stimulated eryptosis [170]
Fluorescent refrigerator lights, while not as damaging as sunlight, still contribute to photodegradation over weeks of exposure
All participants were instructed to eat 800 fewer calories per day than needed to maintain their current weight and to limit dietary fat to 30% of calories